Almac data improves diagnosis of cancer

July 2011
Worldwide Biotech;Jul2011, Vol. 23 Issue 7, p1
Trade Publication
The article shows the 2 primary research projects of Almac that enhance cancer screening. The first study focuses on ovarian cancer screening using the profiling process of a big clinical dataset of 363 sampled patients, where 6 molecular subgroups and 3 main biological subgroups of the cancer are identified from the patients. The other study assesses breast cancer screening, where the DNA damage response deficient molecular subgroup that has the potential to enhance chemotherapy or assess gene damage.


Related Articles

  • Nearly all women miscalculated their risk for breast cancer. Leiser, Mark; Todak, Alexandra // Hem/Onc Today;9/25/2013, Vol. 14 Issue 18, p23 

    The article discusses an analysis by New York researcher Jonathan D. Herman and colleagues which revealed that 90% of 9,873 women who underwent breast cancer screening at 21 centers on Long Island, New York have inaccurately perceived their breast cancer risks.

  • Should the management of BC in Hong Kong be different?  // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p8 

    The article discusses a study on the cost-effectiveness of breast cancer screening in Hong Kong, China.

  • Computing cancer. Myers, Andrew // Stanford Medicine;Spring2012, Vol. 29 Issue 1, p4 

    The article offers information on a computer program called C-Path for analysis of breast cancer microscopic images developed by computer scientists and pathologists at Stanford University of Palo Alto, California.

  • Does a better grade of tumour occurring in women under hormone replacement therapy compensate for their lower probability of detection by screening mammography. Estève, J.; Séradour, B.; Jacquemier, J.; Remontet, L. // Journal of Medical Screening;Jun2002, Vol. 9 Issue 2, p70 

    OBJECTIVE: To compare the prognostic factor of breast cancer survival between breast cancer diagnosed in subjects receiving hormone replacement therapy (HRT) before diagnosis to those without such a therapy. Subjects and methods: All breast cancers diagnosed between 1993 and 2000 within the...

  • Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland. Heinävaara, S; Sarkeala, T; Anttila, A // British Journal of Cancer;9/23/2014, Vol. 111 Issue 7, p1463 

    Background:Overdiagnosis is the most important adverse event of breast cancer screening with the estimates ranging from 0% to 40-50% depending on invitational age and methods. We updated the estimates of overdiagnosis in Helsinki service screening study in Finland by comparing the observed and...

  • Public Service Announcements Are Effective in Getting Black Women to Screen for Breast Cancer Filed in Research & Studies on February 8, 2013.  // Journal of Blacks in Higher Education (BruCon Publishing Co.);2/14/2013, p4 

    The article reports that a study which states that public service announcements targeted at African American women are effective in increasing the awareness among black women on screenings, and preventive steps against breast cancer.

  • Mammogram value extends to elderly, study finds.  // Journal of Business (10756124);1/14/2016, Vol. 31 Issue 2, pB9 

    The article reports on the study published in the "American Journal of Medicine" led by physician Charles H. Hennekens which revealed that older women who get a mammogram every year have a lower breast cancer mortality compared to those who do not.

  • Women's satisfaction of the Maltese breast screening programme: a cross-sectional survey. Marmara, Danika; Curtis, Judi; Marmara, Vincent // Malta Medical Journal;2015, Vol. 27 Issue 4, p13 

    Introduction: Breast cancer is the most common form of cancer among women,1 with 425,000 new cases diagnosed in Europe each year.2 The latter posed a detrimental health problem for years in Malta and consequently, a National Breast Screening Programme was established in 2009. Previous studies...

  • Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: the Kenyan experience. Sayed, Shahin; Moloo, Zahir; Bird, Peter; Wasike, Ronald; Njoroge, Wambui; Karanu, Joseph; Nzioka, Ancent; Sherman, Omar; Prasad, Satya; Mariwa, Costa; Otieno, James Obondi; Chumba, David; Koech, David; Mbinga, Daniel; Mohammed, Musa; Njoroge, Richard; Chauhan, Rajendra; Vinayak, Sudhir; Kyobutungi, Catherine; Saleh, Mansoor // Journal of Clinical Pathology;Apr2013, Vol. 66 Issue 4, p307 

    INTRODUCTION The majority of women with breast cancer in Kenya present with node-positive (stage II) or locally advanced Q7 disease (stage IIIB). Diagnosis is made on fine needle aspirate cytology and treatment is with surgery if resectable. Diagnostic core biopsy is available only at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics